Study S002087

A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT02288273
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: TRIPLE
Status: COMPLETED
Enrollment: 239
Start: 2014-12
Primary completion: 2015-08
Lead sponsor: AstraZeneca
Conditions: Type 2 Diabetes
Interventions: DRUG:Bydureon; DRUG:Placebo
Results posted: TRUE

Registered primary outcomes

Change in 24-hour Mean Weighted Glucose [Day 27/28]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.